Greetings! AAPS is proud to share the announcement of the upcoming conference by our partner project Cannabis 360.

Annual Virtual

Conference

September 29, 2022

Early Bird Sale Ending Soon!

Join industry leaders sharing pivotal insights and cutting-edge knowledge on cannabis and psychedelics

Greetings!

Cannabis 360 features industry leaders and experts covering important issues and current challenges related to cannabis and psychedelics. Cannabis 360 aims to provide key insights on the biggest opportunities within these emerging markets, both in Canada and abroad. Our speakers will provide actionable takeaways for attendees, whether you are new to the industry, or an established business searching for growth opportunities.

We encourage industry professionals—from cultivators, manufacturers, retail operators, consultants, lawyers, investors, regulators, medical professionals, scientists, and researchers —join us at the Cannabis 360 Conference to receive expert training and insights across a variety of sectors and disciplines.

Don't miss out on our early bird special running until July 22!

FEATURING

Adam Greenblatt

Consultant/Educator

Nicholas Nedin

Product Development/QA

Greenway Greenhouse

Peter Cogan

Associate Professor of Pharmaceutical Sciences

Regis University

Hardeep Shoker

Chief Product Officer

Elevated Signals

Sabrina Ramkellawan

COO

Knowde Group

Buy Tickets

Conference Schedule

Terpenes and the Entourage Effect: Separating the Science from Marketing Buzz

The entourage effect has become widely adopted by the cannabis industry with proponents insisting that cannabinoids work along with terpenes to create certain effects associated with cannabis consumption. However, scientific evidence for the entourage effect is limited and further research is still required. In this panel, our panelist will provide a comprehensive breakdown this often-misunderstood phenomenon.

Creating Operational Efficiency Through Technology

Compliance has remained an integral part of the cannabis industry with technology evolving rapidly over the last few years to help companies reduce costs, human error, and inefficient processes within the facility. Panelist will discuss how technology can be utilized to save you time and money, move beyond traditional record keeping practice, reduce organizational risk and ensure that you always remain compliant while also improving workflow and process efficiency.

The Future of Clinical Trials with Psychedelics

In clinical research settings around the world, renewed investigations are taking place on the use of psychedelic substances for treating illnesses such as addiction, depression, anxiety, and posttraumatic stress disorder (PTSD). The panel of experts will briefly discuss the different phases of clinical trials, the research design process, challenges related to site selection and how they envision clinical trials with psychedelics progressing over the next several years.